Profil
Mr. Marty D.
Mann is Partner at Foley & Lardner LLP.
His practice focuses on acquisitions and financings for public and private companies and venture capital investments.
Mr. Mann was previously employed as a Partner by 20 and as an Investment Banker by Drexel Burnham Lambert Real Estate Associates II.
Mr. Mann received a BS in Economics, magna cum laude, from the University of Pennsylvania-The Wharton School of Finance and Commerce and a JD degree from Stanford University.
Ehemalige bekannte Positionen von Marty D. Mann
| Unternehmen | Position | Ende |
|---|---|---|
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Private Equity Investor | 28.02.2011 |
Drexel Burnham Lambert Real Estate Associates II
Drexel Burnham Lambert Real Estate Associates II Real Estate Investment TrustsFinance Operates a REIT | Corporate Officer/Principal | - |
Ausbildung von Marty D. Mann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Drexel Burnham Lambert Real Estate Associates II
Drexel Burnham Lambert Real Estate Associates II Real Estate Investment TrustsFinance Operates a REIT | Finance |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Finance |
















